O6-Methylguanine-DNA Methytransferase (MGMT) Immunohistochemistry as a Predictor of Resistance to Temozolomide in Primary CNS Lymphoma

被引：0
|
作者：
Jiang, X.
Reardon, D. A.
Desjardins, A.
Vredenburgh, J. J.
Quinn, J. A.
Austin, A. D.
Herndon, J. E.
McLendon, R. E.
Friedman, H. S.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1620
引用
收藏
页码：382A / 382A
页数：1
相关论文
共 50 条
  • [41] Leukemia cells are sensitized to temozolomide, carmustine and melphalan by the inhibition of O6-methylguanine-DNA methyltransferase
    Arai, Hajime
    Yamauchi, Takahiro
    Uzui, Kanako
    Ueda, Takanori
    ONCOLOGY LETTERS, 2015, 10 (02) : 845 - 849
  • [42] SURVIVAL PREDICTION BY MULTIPLE O6-METHYLGUANINE-DNA METHYLTRANSFERASE TESTINGS FOR GLIOBLASTOMA TREATED WITH TEMOZOLOMIDE
    Nagane, Motoo
    Kobayashi, Keiichi
    Shimizu, Saki
    Waha, Andreas
    Shiokawa, Yoshiaki
    NEURO-ONCOLOGY, 2009, 11 (05) : 645 - 645
  • [43] Impact of accuracy in O6-methylguanine-DNA methyltransferase methylation assays for temozolomide efficacy on glioblastoma
    Nagane, Motoo
    Kobayashi, Keiichi
    Shimizu, Saki
    Shiokawa, Yoshiaki
    Waha, Andreas
    CANCER RESEARCH, 2010, 70
  • [44] Effect of alternative temozolomide schedules on glioblastoma O6-methylguanine-DNA methyltransferase activity and survival
    C G Robinson
    J M Palomo
    G Rahmathulla
    M McGraw
    J Donze
    L Liu
    M A Vogelbaum
    British Journal of Cancer, 2010, 103 : 498 - 504
  • [45] The temozolomide O6-methylguanine-DNA methyltransferase (MGMT) study: A phase II trial to evaluate the effect of low-dose preoperative neoadjuvant temozolomide on brain tumour MGMT activity in glioma patients
    Del Maestro, R. F.
    Siu, V.
    Sadr, M. Seyed
    Alshami, J.
    Sabau, C.
    Sadr, E. Seyed
    Samani, A.
    Assadian, S.
    Greaves, K.
    Pouliot, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a prognostic factor in anaplastic astrocytomas
    Tosoni, A.
    Franceschi, E.
    Ermani, M.
    Poggi, R.
    La Torre, L.
    Tomasello, C.
    Marucci, G.
    Maestri, A.
    Bartolini, S.
    Brandes, A. A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 500 - 500
  • [47] O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET)
    Lemelin, Annie
    Barritault, Marc
    Hervieu, Valerie
    Payen, Lea
    Peron, Julien
    Couvelard, Anne
    Cros, Jerome
    Scoazec, Jean-Yves
    Bin, Sylvie
    Villeneuve, Laurent
    Lombard-Bohas, Catherine
    Walter, Thomas
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (04) : 595 - 599
  • [48] Gemox or Alkylating Agents in Neuroendocrine Tumors? The Help of O6-Methylguanine-DNA Methyltransferase (MGMT) Status?
    Dussol, A. S.
    Joly, M. O.
    Hervieu, V
    Forestier, J.
    Lombard-Bohas, C.
    Cassier, P.
    Scoazec, J. Y.
    Walter, T.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 118 - 118
  • [49] Evaluation of Methylation of MGMT (O6-Methylguanine-DNA Methyltransferase) Gene Promoter in Sporadic Colorectal Cancer
    Farzanehfar, Mohammadreza
    Vossoughinia, Hasan
    Jabini, Raheleh
    Tavassoli, Alireza
    Saadatnia, Hasan
    Khorashad, Ahmad Khosravi
    Ahadi, Mitra
    Afzalaghaee, Monavvar
    Karimiani, Ehsan Ghayoor
    Mirzaei, Farzaneh
    Ayatollahi, Hossein
    DNA AND CELL BIOLOGY, 2013, 32 (07) : 371 - 377
  • [50] O6-methylguanine-DNA methyltransferase (MGMT) Promoter methylation is a rare event in soft tissue sarcoma
    Jens Jakob
    Maren Hille
    Christian Sauer
    Philipp Ströbel
    Frederik Wenz
    Peter Hohenberger
    Radiation Oncology, 7
12345